Fig. 2From: Applicability of adipose-derived mesenchymal stem cells in treatment of patients with type 2 diabetesThe effects of T2DM on AD-MSCs. T2DM-related metabolic dysfunction impair AD-MSC functionalities including undifferentiated multipotent potential, proliferation, apoptosis, senescence, and immunomodulationBack to article page